bisacodyl laxative (psm healthcare)
psm healthcare ltd trading as api consumer brands - bisacodyl 5mg - enteric coated tablet - 5 mg - active: bisacodyl 5mg excipient: carnauba wax hyprolose hypromellose methacrylic acid copolymer eudragit l 100 iron oxide yellow isopropyl alcohol lactose monohydrate magnesium stearate methacrylic acid copolymer microcrystalline cellulose purified talc purified water starch sucrose titanium dioxide triethyl citrate - short term relief of constipation
bisacodyl viatris
viatris limited - bisacodyl 5mg - enteric coated tablet - 5 mg - active: bisacodyl 5mg excipient: carnauba wax hyprolose hypromellose methacrylic acid copolymer, eudragit s 100 iron oxide yellow isopropyl alcohol lactose monohydrate magnesium stearate methacrylic acid copolymer microcrystalline cellulose purified talc purified water starch sucrose titanium dioxide triethyl citrate - short term relief of constipation
bisacodyl 5mg tabs tablet
gracure pharmaceuticals ltd e-i105 industrial area phase-iii bhiwadi - bisacodyl 5mg - tablet - bisacodyl 5mg - drugs for constipation: contact laxatives
dulcolax bisacodyl 5 mg coat. tabl.
opella healthcare belgium sa-nv - bisacodyl 5 mg - coated tablet - 5 mg - bisacodyl 5 mg - bisacodyl
gavilyte-h and bisacodyl- polyethylene glycol 3350, sodium chloride, sodium bicarbonate, potassium chloride and bisacodyl delaye
lupin pharmaceuticals, inc. - bisacodyl (unii: 10x0709y6i) (deacetylbisacodyl - unii:r09078e41y) - bisacodyl 5 mg - gavilyte - h and bisacodyl delayed-release tablet, usp is indicated for cleansing of the colon as a preparation for colonoscopy in adults. the gavilyte - h and bisacodyl delayed-release tablet, usp is contraindicated in the following conditions: - gastrointestinal (gi) obstruction - bowel perforation - toxic colitis and toxic megacolon - gastric retention - ileus pregnancy category c animal reproduction studies have not been conducted. it is not known whether gavilyte - h and bisacodyl delayed-release tablet, usp can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. gavilyte - h and bisacodyl delayed-release tablet, usp should be given to a pregnant or nursing woman only if clearly needed. it is not known whether this drug is excreted in human milk. because many drugs are excreted in human milk, caution should be exercised when gavilyte - h and bisacodyl delayed-release tablet, usp is administered to a nursing woman. safety and effectiveness in pediatric patients has
bisacodyl 5mg gastro-resistant tablets
medreich plc - bisacodyl - gastro-resistant tablet - 5mg
bisacodyl 5mg gastro-resistant tablets
a a h pharmaceuticals ltd - bisacodyl - gastro-resistant tablet - 5mg
bisacodyl 5mg gastro-resistant tablets
actavis uk ltd - bisacodyl - gastro-resistant tablet - 5mg
bisacodyl 5mg gastro-resistant tablets
kent pharma (uk) ltd - bisacodyl - gastro-resistant tablet - 5mg
bisacodyl 5mg gastro-resistant tablets
alliance healthcare (distribution) ltd - bisacodyl - gastro-resistant tablet - 5mg